Biosensors Market Global Forecast to 2024
The Biosensors Market is expected to grow from USD 21.2 billion in 2019 to USD 31.5 billion by 2024, at a CAGR of 8.3%, finds a report by MarketsandMarkets.
The report further divulges that factors such as continuous technological advancements in biosensors ecosystem, increase in the use of biosensors for nonmedical applications, lucrative growth in POC diagnostics, and rise in demand for glucose monitoring systems are driving the growth of the biosensors market.
The growth of embedded devices is attributed to its implementation in environment monitoring, biodefence, and food & beverages to detect and remove contaminants, whether nonliving or living entities. These biosensors can be used for the detection of a broad spectrum of biological analytes and have shown greater responses and success in medical laboratories, food bioanalysis, and microbial detection.
Detection of lower or higher limits of glucose in the body, microbial invasion in body and food, heavy metals detection in soil and water, air-borne microbes and pesticides in water and soil, and various harmful chemicals produced by the body can be easily and timely monitored with precision using the different types of embedded biosensors.
Wearable biosensors can be considered as among the major developments in healthcare technology. Wearable devices monitoring health consist of different types of miniature biosensors capable of measuring physiological parameters, such as vital signs (heart rate, respiration rate, body and skin temperature, and oxygen saturation), skin conductance, blood pressure, electrocardiogram (ECG), electroencephalography (EEG), acceleration, and rotation.
North America held the largest size of the biosensor market in 2019. PoC diagnostics is the fastest-growing application for biosensors in North America. The growth is attributed to the increase in addressable patient population.
Key players operating in the biosensor market include Abbott Point of Care Inc., Medtronic Inc., LifeScan Inc., Universal Biosensors Inc., F. Hoffman-La Roche Ltd., DuPont, Sysmex Corporation, Bio-Rad laboratories Inc., Pharmaco-Kinesis Corporation, Nova Biomedical Corp., ACON Laboratories, Inc., LifeSensors Inc., Biacore, and Biosensors International Pte. Ltd.
Further information on the report: Click Here
